MECTIMITE TABLETS: A Comprehensive Guide to Usage and Precaution

Composition:

Each filmcoated MECTIMITE TABLETS   tablet contains 3mg & 6mg
Ivermectin USP

Drug Description:

MECTIMITE TABLETS (Ivermectin) is a semisynthetic
anti-helminthic agent derived from the avermectins, effectively treating various
parasitic infections such as scabies, strongyloidiasis, and onchocerciasis

Indications:

Mectimite is indicated for scabies treatment,
non-disseminated strongyloidiasis, and onchocerciasis caused by Strongyloides
stercoralis and Onchocerca volvulus, respectively

Dosage and Administration:

The recommended dosage for
scabies and strongyloidiasis is a single oral dose providing about 200 mcg of
Ivermectin per kg of body weight For onchocerciasis, a single oral dose
providing approximately 150 mcg of Ivermectin per kg of body weight is
recommended

Side Effects:

Ivermectin is generally well-tolerated, with
side effects such as asthenia, abdominal discomfort, constipation, diarrhea,
dizziness, pruritus, and rash reported

Drug Interactions and Precautions:

Co-administration of
Ivermectin with warfarin may rarely lead to increased INR Precautions must be
taken during pregnancy, lactation, and pediatric use Careful consideration is
advised for elderly patients with hepatic, renal, or cardiac function
impairment

Storage and Presentation:

Mectimite tablets 6mg are
presented in blister packs of 1×10 and should be stored below 25 °C

For the treatment of parasitic infections, Mectimite offers
a safe and effective therapeutic option, with minimal side effects and
comprehensive guidelines for use in specific patient populations Always consult
a healthcare professional for individualized guidance and dosage recommendations